close
Health

PPP001 the first pharmaceutical pills approved by Health Canada

Blog-Cannabis

Health Canada is in the process of approving the first (dried) cannabis pill. The drug PPP001 is manufactured in Moncton by a pharmacist, in collaboration with Tétra Bio-Pharma

The first cannabis pill approved by Health Canada will soon be on the market. This new drug resulting from the collaboration of a pharmacist and Tétra Bio-Pharma is in the process of being approved. This pill is a first on the pharmaceutical market, it will be very different from what is currently done and will be more easily prescribed.

The cannabis pill (dried)

Currently the only pharmaceutical drug (based on non-synthetic cannabis) distributed (even in France), is Sativex. Other drugs from synthetic THC have emerged, but the PPP001 pill will have the merit of being natural, and based on dried cannabis. We owe this feat to pharmacist Peter Ford of Moncton, who worked with the pharmaceutical company Tétra Bio-Pharma, a listed company.

PPP001, Tetra Bio-Pharma, pharmacist, pill
Peter Ford in his pharmacy on St. George Street. Photo: Radio-Canada / Nicolas Steinbach

Pharmacist Peter Ford has been making drugs for 35 years in his little lab on St. George Street in Moncton. And for a year and a half, he has embarked on a whole new adventure, namely to make the first pill made entirely of dried cannabis.

to read :  Topical hemp

I did my doctoral thesis on cannabis and I realized that it was a remarkable productexplains the apothecary.

PPP001 relieves chronic pain

The drug PPP001, will primarily be used to relieve chronic pain and patients in the terminal phase of cancer. Its specificity is found in the purity of the cannabis used. This means that we make it without any additives. If we take a closer look, the pill contains 9,5% tetrahydrocannabinol (THC) et 2,5% cannabidiol (CBD)

I have 80 year old patients who are now talking about CBD, THC and this is really something that I have never seen in my life as a pharmacist.

In addition, the PPP001 pill may replace opioid treatment, such as fentanyl. He will avoid all the inconvenients treatment with opiates, such as respiratory depression, and overdoses… Patients will have a better quality of life, according to Guy Chamberland, director and chief scientific officer of
PPP001, Tetra Bio-Pharma, pharmacist, pill
Guy Chamberland, Chief Scientific Officer of Tetra Bio-Pharma. Photo: Radio-Canada

A medicine distributed in Europe?

But Health Canada doesn't quite consider medical cannabis to be a drug ... However, Tetra Bio-Pharma wants its pill to take the final step that will allow it to be prescribed by doctors.

We want to have a Drug Identification Number from Health Canada. This number allows patients to get reimbursed by insurance, because recreational cannabis is notadds Ford. In addition, everyone can get this drug, as it will be prescribed. In addition, it will not only be reserved for adults.

If the process goes well, PPP001 could be on the market by the end of the year. The pill is currently undergoing the final stage of clinical trials, and is awaiting approval by Health Canada. If fully approved, it will be made in Peter Ford's lab (in the basement of his pharmacy). Pharmacist Peter Ford and Tetra Bio-Pharma hope to sell the drug in Canada, but also in the United States and Europe.
PPP001, Tetra Bio-Pharma, pharmacist, pill
The cannabis used for the drug comes from, among others, Ontario-based producer Aphria. Photo: Radio-Canada / Nicolas Pham
Tags : CanadaMedicalPharmacyTreatment
Weed-master

The author Weed-master

Weed media broadcaster and communications manager specializing in legal cannabis. Do you know what they say? knowledge is power. Understand the science behind cannabis medicine, while staying up to date with the latest health related research, treatments and products. Stay up to date with the latest news and ideas on legalization, laws, political movements. Discover tips, tricks and how-to guides from the most seasoned growers on the planet as well as the latest research and findings from the scientific community on the medical qualities of cannabis.